Join the Wegovy group to help and get support from people like you.
Wegovy News (Page 5)
FDA Approves Wegovy to Lower Risk for CVD Events in Patients With Obesity
FRIDAY, March 8, 2024 – The U.S. Food and Drug Administration has approved Wegovy (semaglutide) for the prevention of myocardial infarction, stroke, and cardiovascular death in patients with obesity...
FDA Approves Wegovy to Help Prevent Heart Attack, Stroke
FRIDAY, March 8, 2024 – Wegovy (semaglutide), the weight-loss version of blockbuster diabetes drug Ozempic, was approved on Friday by the U.S. Food and Drug Administration to help prevent heart...
Wegovy Approved in the US for Cardiovascular Risk Reduction in People with Overweight or Obesity and Established Cardiovascular Disease
Bagsværd, Denmark, 8 March 2024 – Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved a label expansion for Wegovy based on a supplemental New Drug Application (s...
Wegovy, Ozempic Use Could Complicate Your Surgery
WEDNESDAY, March 6, 2024 – Weight-loss drugs like Wegovy and Ozempic can increase a person’s risk of throwing up during surgery while under anesthesia, a new study reports. People are typically a...
How to Keep the 'Ozempic Effect' Going: Exercise
FRIDAY, Feb. 23, 2024 – An open question for weight-loss drugs like Ozempic, Wegovy and Zepbound has been whether folks will keep the pounds off when they stop taking them. Regular exercise could be...
Novo Nordisk Settles Lawsuits Over Copycat Versions of Ozempic, Wegovy
MONDAY, Feb. 12, 2024 — Novo Nordisk has settled lawsuits against two Florida businesses that claimed to sell copycat versions of its popular weight-loss drugs Ozempic and Wegovy. The Danish d...
FDA Medwatch Alert: Drug Safety Communication: Certain Type of Medicines Approved for Type 2 Diabetes and Obesity - Update on FDA’s Ongoing Evaluation of Reports of Suicidal Thoughts or Actions
ISSUE: The FDA has been evaluating reports of suicidal thoughts or actions in patients treated with a class of medicines called glucagon-like peptide-1 receptor agonists (GLP-1 RAs; see the list in...
Suicidal Behaviors Do Not Appear Associate with Wegovy, Ozempic; FDA
FRIDAY, Jan. 12, 2024 – In a preliminary review, the U.S. Food and Drug Administration says it has found no evidence drugs like Wegovy and Ozempic cause suicidal thoughts or actions. Still, the...
FDA Finds No Link to Suicide With Drugs Like Wegovy, Ozempic
FRIDAY, Jan. 12, 2024 – Drugs like Wegovy and Ozempic, which have become a wildly popular way to lose weight or battle diabetes, show no link to suicidal thoughts or actions, the U.S. Food and Drug...
Risk for Suicidal Ideation Not Increased With Semaglutide
TUESDAY, Jan. 9, 2024 – For individuals with overweight or obesity and type 2 diabetes, semaglutide is not associated with an increased risk for suicidal ideation compared with non-glucagon-like...
Reddit Posts Show Ozempic, Wegovy Cutting Users' Alcohol Use
TUESDAY, Jan. 9, 2024 – Social media is abuzz with the possibility that newfangled weight loss drugs can also reduce cravings for alcohol, a new study says. Across a number of Reddit threads, users...
Consumption of Ultra-Processed Foods Tied to Upper Digestive Tract Cancers
FRIDAY, Dec. 22, 2023 – Higher ultra-processed food (UPF) consumption is associated with a greater risk for head and neck cancer (HNC) and esophageal adenocarcinoma (OAC), according to a study...
Use of Noninsulin Antidiabetic Meds Increasing for T2D in Pregnancy
WEDNESDAY, Dec. 13, 2023 – Use of second-line noninsulin antidiabetic medications (ADMs) is increasing for type 2 diabetes (T2D) in pregnancy, but use is not associated with a significantly...
Most Older Americans Think Medicare Should Cover Weight-Loss Meds: Poll
WEDNESDAY, Dec. 13, 2023 – An overwhelming majority of older Americans think health insurers and Medicare should cover the cost of weight-loss medications like Ozempic, Wegovy or Zepbound, a new...
Risk for CRC Reduced With GLP-1RAs for Drug-Naive Patients With T2D
MONDAY, Dec. 11, 2023 – For drug-naive patients with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonists (GLP-1RAs) are associated with a reduced risk for colorectal cancer (CRC)...
Further information
Related condition support groups
Weight Loss (Obesity / Overweight), Cardiovascular Risk Reduction